InsightRX vs PrecisePK

Last VerifiedAugust 4, 2026
Verdict

The two most inspectable dosing platforms in the index, which makes this the closest comparison in the segment. InsightRX runs published population pharmacokinetic models rather than proprietary ones, holds certified Epic marketplace integration and published an analysis of more than 168,000 treatment courses, the nearest thing to post deployment monitoring anyone here offers. PrecisePK holds the best independent comparative result in the category and explains its computation openly, with a sixty day evaluation so a pharmacy can test its own cases. Both let you see the science, which is the point. The separator is institutional: InsightRX publishes the assurance and integration credentials a hospital procurement will ask for, and PrecisePK publishes none of them.

Select InsightRX if
  • The population pharmacokinetic models it runs are published rather than proprietary, so a pharmacy can read the science behind the recommendation.
  • Certified Epic marketplace integration and a published analysis of more than 168,000 treatment courses, which is the closest thing to post deployment monitoring in the segment.
  • Automatic import is limited to the data the dosing calculation needs rather than bulk extraction.
Select PrecisePK if
  • The best independent comparative result in this category, which no amount of vendor evidence substitutes for.
  • The computation is walked through in sequence on the vendor's own site, which is unusually open for a product of this kind.
  • A sixty day evaluation is offered, so a pharmacy can test it against its own cases before committing.
Attribute Matrix

Side by Side

Axis
I
InsightRX
P
PrecisePK
AI Centrality
Autonomy and Oversight Model
Model and Technology Transparency
Clinical and Operational Evidence
AI Safety and PHI Stewardship
HIPAA and BAA Posture
Security Certifications and Trust Center
FDA and Regulatory Status
AI Governance and Bias Disclosure
EHR and Interoperability Depth
Deployment Model and Data Residency
Commercial Transparency
Setting and Specialty Coverage
Keep Comparing

Related comparisons

Other published head to head assessments involving these vendors or their closest peers. The full set for this category is on the Clinical Decision Support page.

Disclosure

The independent comparison in this segment included multiple platforms and did not find them equivalent across every drug and scenario, so ask each vendor how it performed for the specific agents your service doses rather than in aggregate. Neither holds a device clearance.

PrecisePK publishes no security attestation, health privacy statement or business associate terms, and neither vendor publishes performance by renal function band, body habitus, age, sex or race, which are the variables that actually move a dose.

AI Health Index

An independent reference for evaluating AI vendors in healthcare. No vendor pays for inclusion, placement, or rating.

Index Status
Last index update
August 4, 2026
The AI Health Index is an editorial reference, not a regulatory body. Vendor data is verified against published sources and public regulatory filings. Figures labeled “Estimated” have not been confirmed by the vendor. See the Methodology page for evaluation standards and limitations.
© 2026 AI Health Index
3801 N Capital of Texas Hwy, Ste E240 · Austin, TX 78746